Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Simplesa Nutrition is a nutraceutical company specializing in high-quality nutritional supplements designed to support individuals with neurodegenerative diseases. The company is most notably recognized for providing the components of the Deanna Protocol, a metabolic support program specifically developed for patients with Amyotrophic Lateral Sclerosis (ALS). Simplesa focuses on simplifying complex supplement regimens by offering scientifically formulated blends that target mitochondrial health and reduce oxidative stress. Their product line includes various amino acids, antioxidants, and vitamins tailored for conditions such as Parkinson's and Alzheimer's. By collaborating with researchers and patient communities, Simplesa aims to improve the quality of life for those facing chronic neurological challenges through targeted nutritional intervention.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Simplesa Nutrition.